Core Viewpoint - Renhe Pharmaceutical (000650) indicates that there are currently no specific drugs or vaccines for the prevention of rhinovirus, emphasizing the importance of cutting off droplet and contact transmission, personal and environmental protection, and enhancing immunity [1] Company Products - The company offers several products for symptomatic relief from rhinovirus infections, including Ibuprofen capsules, Compound Paracetamol and Amantadine capsules, and Strong Loquat capsules [1]

Core Viewpoint - The company, Renhe Pharmaceutical, confirmed the availability of several influenza treatment medications and emphasized its commitment to ensuring stable production and supply to meet market demand [2]. Product Information - The company currently sells influenza treatment medications including Oseltamivir Phosphate Capsules, Ibuprofen Sustained-Release Capsules, Amoxicillin Capsules, Compound Aminophenol and Amantadine Capsules, Strong Loquat Capsules, and Pediatric Acetaminophen Granules [2]. - In addition to these, the company offers various medications for symptoms related to influenza-like illnesses, providing consumers with multiple options for symptomatic relief [2]. Supply Assurance - The company has prioritized the supply of these influenza-related medications to ensure they meet market demand effectively [2].